NCT06049004

Brief Summary

The Londrina Activities of Daily Living Protocol was first developed for Chronic Obstructive Pulmonary Disease patients and was found to be valid and reliable, but there is no validity and reliability study of the Londrina Activities of Daily Living Protocol in IPF patients. The purpose of the study is to Examine the Validity and Reliability of the Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis (IPF) patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

September 15, 2023

Last Update Submit

June 2, 2025

Conditions

Keywords

idiopathic pulmonary fibrosisactivity daily livingvalidityreliability

Outcome Measures

Primary Outcomes (1)

  • Londrina Activities of Daily Living Protocol

    The protocol is a performance-based objective measurement method based on repetition of daily activities. Participants are asked to perform the activities defined in the protocol at the same speed they do at home. The Londrina Protocol includes 5 stations: Station 1 Arranging Objects on the Table, Station 2 Walking with Bags, Station 3 Organizing Shelves, Station 4 Clothesline Task, Station 5 Walking. The completion time of the protocol is recorded.

    15 minutes

Secondary Outcomes (5)

  • Glittre Activities of Daily Living Test:

    5 minutes

  • London Chest Activities of Daily Living (ADL) Scale

    10 minutes

  • Hand Grip Strength Measurement

    5 minutes

  • mMRC Dyspnea Scale

    5 minutes

  • Respiratory Function Test

    10 minutes

Interventions

The protocol is a performance-based objective measurement method based on repetition of daily activities. Participants are asked to perform the activities defined in the protocol at the same speed they do at home. The Londrina Protocol includes 5 stations: Station 1 Arranging Objects on the Table, Station 2 Walking with Bags, Station 3 Organizing Shelves, Station 4 Clothesline Task, Station 5 Walking. The completion time of the protocol is recorded.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients being diagnosed with idiopathic pulmonary fibrosis (IPF) disease

You may qualify if:

  • Being diagnosed with idiopathic pulmonary fibrosis (IPF) disease
  • Being 18 years or older
  • Being independent in daily living activities
  • Being able to read and understand Turkish

You may not qualify if:

  • The patient refuses to participate in the study
  • People with comorbidities that would make it impossible to perform any of the study evaluations (orthopedic pathology, uncontrolled cardiovascular or neurological conditions, psychiatric illness, etc.)
  • Presence of infection in the last 3 months
  • Those who show changes in their usual symptoms during the protocol
  • Patients who have difficulty understanding the commands given
  • Those who cannot complete all evaluations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Katip Celebi University

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Idiopathic Pulmonary FibrosisMotor Activity

Condition Hierarchy (Ancestors)

Pulmonary FibrosisLung Diseases, InterstitialLung DiseasesRespiratory Tract DiseasesBehavior

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

September 15, 2023

First Posted

September 21, 2023

Study Start

November 1, 2023

Primary Completion

June 1, 2024

Study Completion

November 1, 2024

Last Updated

June 5, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations